We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+34.9%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$492M
AUM Growth
+$152M
Cap. Flow
+$82.8M
Cap. Flow %
16.83%
Top 10 Hldgs %
34.01%
Holding
98
New
29
Increased
22
Reduced
16
Closed
26

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$8.41M
2
ANET icon
Arista Networks
ANET
+$7.11M
3
TEAM icon
Atlassian
TEAM
+$7.05M
4
MSGS icon
Madison Square Garden
MSGS
+$6.69M
5
VAR
Varian Medical Systems, Inc.
VAR
+$6.43M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$6.7M
2
EHTH icon
eHealth
EHTH
+$5.9M
3
UNH icon
UnitedHealth
UNH
+$5.61M
4
ALLK
Allakos
ALLK
+$4.7M
5
FIVE icon
Five Below
FIVE
+$4.66M

Sector Composition

Rank Sector Weight
1 Healthcare 28.63%
2 Technology 16.49%
3 Communication Services 10%
4 Consumer Discretionary 6.21%
5 Materials 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMC icon
51
Vulcan Materials
VMC
$37.2B
$3.85M 0.78%
32,500
+1,500
+5% +$162K
BHVN
52
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.65M 0.74%
+71,000
New +$3.07M
PEN icon
53
Penumbra
PEN
$12.7B
$3.53M 0.72%
+24,000
New +$3.43M
FTCH
54
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$3.5M 0.71%
+130,000
New +$2.91M
PTLA
55
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.47M 0.7%
+100,000
New +$2.89M
TDOC icon
56
Teladoc Health
TDOC
$1.26B
$3.28M 0.67%
59,000
-18,000
-23% -$1.1M
AERI
57
DELISTED
Aerie Pharmaceuticals
AERI
$3.09M 0.63%
+65,000
New +$2.86M
BMRN icon
58
BioMarin Pharmaceuticals
BMRN
$11.6B
$3.06M 0.62%
34,500
+500
+1% +$46.3K
MOH icon
59
Molina Healthcare
MOH
$10.2B
$2.98M 0.61%
21,000
-17,000
-45% -$2.3M
NVCR icon
60
NovoCure
NVCR
$1.87B
$2.79M 0.57%
58,000
-2,500
-4% -$120K
VNDA icon
61
Vanda Pharmaceuticals
VNDA
$306M
$2.59M 0.53%
141,000
+11,000
+8% +$251K
CHRS icon
62
Coherus Oncology
CHRS
$224M
$2.56M 0.52%
+188,000
New +$2.51M
SPOT icon
63
Spotify
SPOT
$99.2B
$2.51M 0.51%
+18,100
New +$2.48M
FOLD
64
DELISTED
Amicus Therapeutics
FOLD
$2.24M 0.46%
+165,000
New +$2.02M
LKFT
65
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.71B
$2.24M 0.45%
19,000
-10,200
-35% -$1.03M
RCKT icon
66
CALL
Rocket Pharmaceuticals
RCKT
$382M
$2.19M 0.45%
+125,000
New +$1.97M
UNH icon
67
UnitedHealth
UNH
$375B
$1.36M 0.28%
5,500
-22,000
-80% -$5.61M
ATEX icon
68
Anterix
ATEX
$1.94B
$1.34M 0.27%
+38,000
New +$1.49M
DBD
69
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
$1.11M 0.22%
100,000
-100,000
-50% -$699K
NTNX icon
70
Nutanix
NTNX
$16.5B
$831K 0.17%
+22,000
New +$1.01M
MDGL icon
71
CALL
Madrigal Pharmaceuticals
MDGL
$11.9B
$754K 0.15%
27,000
+7,000
+35% +$870K
MDCO
72
CALL
DELISTED
Medicines Co
MDCO
$425K 0.09%
15,200
-6,900
-31% -$163K
ALGN icon
73
Align Technology
ALGN
$12.5B
– –
-19,554
Closed -$4.09M
ALLK
74
DELISTED
Allakos
ALLK
– –
-90,000
Closed -$4.7M
ASH icon
75
CALL
Ashland
ASH
$3.28B
– –
-62,000
Closed -$4.4M
1 2
3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
LWM
Liberty Wealth Management Oakland, California $800M AUM 20.44% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return

Atika Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Atika Capital Management held 98 positions worth $492M, up 45% from $340M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Atika Capital Management deployed $82.8M of net new capital in Q1 2019, opening 29 new positions and adding to 22 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 56,500 shares worth $9.52M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was eHealth, an estimated $5.9M trimmed.

  • Atika Capital Management's largest Q1 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 56,500 shares worth $9.52M.
  • Atika Capital Management added most to Arista Networks in Q1 2019, an estimated $7.11M increase.
  • Atika Capital Management's biggest Q1 2019 reduction was eHealth, cutting an estimated $5.9M.
  • Atika Capital Management fully exited Elevance Health in Q1 2019, selling an estimated $6.7M.
  • Atika Capital Management's ten largest holdings make up 34% of its $492M portfolio in Q1 2019.
  • Atika Capital Management opened 29 new positions and closed 26 in Q1 2019.
  • Atika Capital Management's portfolio value rose 45% quarter-over-quarter to $492M.

Based on Atika Capital Management's 13F filing for Q1 2019, filed 13 May 2019.